IOBT
IO Biotech, Inc.NASDAQHealthcare$0.03+48.61%ClosedMarket Cap: $2.3M
As of 2026-04-06
Valuation
P/E (TTM)
—
PEG
—
P/B
3.53
P/S
0.00
EV/EBITDA
0.30
DCF Value
$0.83
FCF Yield
-2347.3%
Div Yield
0.0%
Margins & Returns
Gross Margin
0.0%
Operating Margin
0.0%
Net Margin
0.0%
ROE
-465.4%
ROA
-221.1%
ROIC
-406.0%
Income Statement
| Period | Revenue | Gross Margin | Operating Income | Net Income | EPS | Dividend |
|---|---|---|---|---|---|---|
| Q3 2025 | $0.00 | -Infinity% | $-19.4M | $-8.4M | $-0.13 | — |
| Q2 2025 | $0.00 | -Infinity% | $-23.2M | $-26.2M | $-0.40 | — |
| Q1 2025 | $0.00 | -Infinity% | $-22.6M | $-22.4M | $-0.34 | — |
| Q4 2024 | $0.00 | -Infinity% | $-26.9M | $-31.3M | $-0.48 | — |
| FY 2024 | $0.00 | -Infinity% | $-95.2M | $-95.5M | $-1.45 | — |
| Q3 2024 | $0.00 | -Infinity% | $-26.5M | $-24.0M | $-0.36 | — |
| Q2 2024 | $0.00 | -Infinity% | $-21.5M | $-20.7M | $-0.31 | — |
| Q1 2024 | $0.00 | -Infinity% | $-20.2M | $-19.5M | $-0.30 | — |
| Q4 2023 | $0.00 | -Infinity% | $-28.2M | $-26.2M | $-0.40 | — |
| FY 2023 | $0.00 | -Infinity% | $-91.4M | $-86.1M | $-1.98 | — |
| Q3 2023 | $0.00 | -Infinity% | $-23.5M | $-21.7M | $-0.43 | — |
| Q2 2023 | $0.00 | -Infinity% | $-21.9M | $-21.2M | $-0.73 | — |